Vanguard Fiduciary Trust
WST icon

Vanguard Fiduciary Trust’s West Pharmaceutical WST Stock Holding History

Vanguard Fiduciary Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142M Sell
396,602
-8,502
-2% -$2.6M 0.03% 435
2026
Q1 		$102M Buy
+405,104
New +$101M 0.03% 505

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Fiduciary Trust's WST Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its West Pharmaceutical (WST) stake by 2.1% in Q2 2026, selling an estimated $2.6M and leaving 396,602 shares worth $142M. The position accounts for 0.03% of the portfolio, ranked #435.

Vanguard Fiduciary Trust first reported a position in WST in Q1 2026 and has held it in 2 quarters since. 821 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Vanguard Fiduciary Trust held 396,602 shares of West Pharmaceutical worth $142M as of Q2 2026.
  • Vanguard Fiduciary Trust sold 8,502 West Pharmaceutical shares in Q2 2026, an estimated $2.6M.
  • West Pharmaceutical made up 0.03% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #435 holding.
  • Vanguard Fiduciary Trust first reported a position in West Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • 821 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.